(Q50940308)

25 March 2018

title

Once daily fluticasone furoate nasal spray is effective in seasonal allergic rhinitis caused by grass pollen (English)

1 reference

25 March 2018

seasonal allergic rhinitis

0 references

1 reference

1 reference

Fokkens WJ

1

1 reference

25 March 2018

Jogi R

2

1 reference

25 March 2018

Reinartz S

3

1 reference

25 March 2018

Sidorenko I

4

1 reference

25 March 2018

Sitkauskiene B

5

1 reference

25 March 2018

van Oene C

6

1 reference

25 March 2018

Faris MA

7

1 reference

25 March 2018

Ellsworth A

8

1 reference

25 March 2018

Caldwell MF

9

1 reference

25 March 2018

publication date

1 September 2007

1 reference

25 March 2018

published in

Allergy

1 reference

25 March 2018

volume

62

1 reference

25 March 2018

issue

9

1 reference

25 March 2018

page(s)

1078-1084

1 reference

25 March 2018

Allergic rhinitis and its impact on asthma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Allergic rhinitis: broader disease effects and implications for management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Diagnosis of allergy syndromes: do symptoms always mean allergy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Implementation of guidelines for seasonal allergic rhinitis: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

Interpretation of rhinoconjunctivitis quality of life questionnaire data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1398-9995.2007.01522.X

10.1111/J.1398-9995.2007.01522.X

21 January 2018

Identifiers

DOI

1 reference

25 March 2018

1 reference

25 March 2018